Investigating Project of the Functional C13 Test "Pilot Study"
NCT01560897 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2012-07-31
Summary
The aim of this pilot study is to evaluate the validity and reproducibility of a functional test "Test C13" ureogenesis to measure in vivo, using the methodology Laboratory of Metabolic Diseases of "Cliniques Universitaires Saint-Luc"
Conditions
- Disorder of the Urea Cycle
Interventions
- DRUG
-
Oral C13
Ingestion of C13 and follow up of the ureogenesis
Sponsors & Collaborators
-
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 2 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2012-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
NCT02460146 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants
NCT06733298 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects
NCT01405599 ·Status: COMPLETED ·Phase: PHASE1
-
13C-Pyruvate Breath Test
NCT01807702 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impairment
NCT05086107 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of BF2.649 in Renal Impairment
NCT01619033 ·Status: COMPLETED ·Phase: PHASE1
-
Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine
NCT01392313 ·Status: WITHDRAWN ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers
NCT03102489 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates
NCT03529617 ·Status: RECRUITING
-
Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment
NCT07033182 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants
NCT06309394 ·Status: COMPLETED ·Phase: PHASE1
-
Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male Subjects
NCT05238714 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]NXL104
NCT01448395 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011
NCT02431481 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects
NCT01796938 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance and Biotransformation Study of [14C]LXI-15028 in Humans
NCT05883306 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders
NCT00992459 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment
NCT01790607 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects
NCT01818232 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy Volunteers
NCT01008631 ·Status: COMPLETED ·Phase: NA
-
A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers
NCT01592890 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NST-6179 in Healthy Subjects
NCT05181085 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)
NCT01465412 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function
NCT00759564 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects
NCT02434835 ·Status: COMPLETED ·Phase: PHASE1